Principal Financial Group’s Cytek Biosciences CTKB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.34M	Sell	534,759 -132,168	-20%	-$624K	﹤0.01%	1805
2025 Q4	$3.37M	Buy	666,927 +43,621	+7%	+$203K	﹤0.01%	1734
2025 Q3	$2.16M	Buy	623,306 +50,919	+9%	+$191K	﹤0.01%	1801
2025 Q2	$1.95M	Buy	572,387 +51,644	+10%	+$172K	﹤0.01%	1806
2025 Q1	$2.09M	Buy	520,743 +13,818	+3%	+$71.6K	﹤0.01%	1761
2024 Q4	$3.29M	Buy	506,925 +3,753	+0.7%	+$22.4K	﹤0.01%	1703
2024 Q3	$2.79M	Buy	503,172 +23,028	+5%	+$131K	﹤0.01%	1720
2024 Q2	$2.68M	Sell	480,144 -38,550	-7%	-$232K	﹤0.01%	1715
2024 Q1	$3.48M	Sell	518,694 -31,729	-6%	-$251K	﹤0.01%	1684
2023 Q4	$5.02M	Sell	550,423 -8,123	-1%	-$51.1K	﹤0.01%	1554
2023 Q3	$3.08M	Buy	558,546 +82,456	+17%	+$661K	﹤0.01%	1675
2023 Q2	$4.07M	Buy	476,090 +433,065	+1,007%	+$3.88M	﹤0.01%	1612
2023 Q1	$395K	Sell	43,025 -4,621	-10%	-$49.7K	﹤0.01%	2026
2022 Q4	$486K	Buy	47,646 +1,634	+4%	+$22K	﹤0.01%	1983
2022 Q3	$678K	Sell	46,012 -52,388	-53%	-$680K	﹤0.01%	1902
2022 Q2	$1.06M	Buy	98,400 +82,510	+519%	+$821K	﹤0.01%	1909
2022 Q1	$171K	Buy	+15,890	New	+$215K	﹤0.01%	2364